US Stock MarketDetailed Quotes
DNTH Dianthus Therapeutics
- 22.550
- +0.780+3.58%
Close May 24 16:00 ET
- 22.550
- 0.0000.00%
Post 16:00 ET
661.83MMarket Cap-7672P/E (TTM)
22.550High20.465Low122.81KVolume21.610Open21.770Pre Close2.72MTurnover0.85%Turnover RatioLossP/E (Static)29.35MShares33.77052wk High1.78P/B325.85MFloat Cap6.58052wk Low--Dividend TTM14.45MShs Float336.000Historical High--Div YieldTTM9.58%Amplitude5.136Historical Low22.153Avg Price1Lot Size
Dianthus Therapeutics Key Stats
EPS
According to the latest financial report of Dianthus Therapeutics, the latest earnings per share (TTM) for the company is -0.54. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Dianthus Therapeutics's free cash flow? The latest report shows it as -14.97M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Dianthus Therapeutics shows that the company's current ratio is 42.52, indicating healthy liquidity.
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Dianthus Therapeutics, the quick ratio is 42.18, indicating that the company can meet its short-term debt obligations.
Quarterly
Loading...
ROE
Want to learn more about the financial health of Dianthus Therapeutics? The latest ROE figure is -5.08%, indicating that the company has stable profitability.
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Dianthus Therapeutics, the total asset return on investment (ROA) is -4.89%.
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Dianthus Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Dianthus Therapeutics, the net profit margin is -1.57K%, which is a good sign for its profitability.
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg